Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary
embolism (PE) is relevant for management decisions but is currently unknown. We …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary
embolism and a major cause of chronic PH leading to right heart failure and death. Lung …

The task of develo** ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background Macitentan is beneficial for long-term treatment of pulmonary arterial
hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension …

Background—Chronic thromboembolic pulmonary hypertension results from incomplete
resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary
hypertension, resulting from fibrotic transformation of pulmonary artery clots causing chronic …

Background—Chronic thromboembolic pulmonary hypertension, a rare complication of
acute pulmonary embolism, is characterized by fibrothrombotic obstructions of large …